1973
DOI: 10.1016/0006-8993(73)90527-1
|View full text |Cite
|
Sign up to set email alerts
|

The role of oligodendroglia and astroglia in wallerian degeneration of the optic nerve

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
27
0

Year Published

1977
1977
2009
2009

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 153 publications
(31 citation statements)
references
References 11 publications
4
27
0
Order By: Relevance
“…One well-characterized response occurs at the site of injury (Amaducci et al, 198 1;Mathewson and Berry, 1985;Schiffer et al, 1986). There are also wellcharacterized examples of increases in GFAP within glial cells at a distance from the site of injury, for example, within degenerating nerves (Vaughn et al, 1970;Cook and Wisniewski, 1973), in areas undergoing retrograde degeneration after axotomy (Graeber and Kreutzberg, 1986;Tetzlaff et al, 1988), or, as in the present study, in areas that would be denervated by the lesion (Rose et al, 1976;Barret et al, 1981;Gage et al, 1988).…”
Section: Discussionsupporting
confidence: 58%
“…One well-characterized response occurs at the site of injury (Amaducci et al, 198 1;Mathewson and Berry, 1985;Schiffer et al, 1986). There are also wellcharacterized examples of increases in GFAP within glial cells at a distance from the site of injury, for example, within degenerating nerves (Vaughn et al, 1970;Cook and Wisniewski, 1973), in areas undergoing retrograde degeneration after axotomy (Graeber and Kreutzberg, 1986;Tetzlaff et al, 1988), or, as in the present study, in areas that would be denervated by the lesion (Rose et al, 1976;Barret et al, 1981;Gage et al, 1988).…”
Section: Discussionsupporting
confidence: 58%
“…Wallerian degeneration in mammalian CNS reportedly proceeds over the course of months or years following an injury. 22 We hypothesize that IFN␤-1a had therapeutic effects in the first year of treatment that were evident on the atrophy measure only in the second treatment year. Ongoing disease activity before study entry may have resulted in brain atrophy during the first year of the study irrespective of the treatment arm assignment, while reduced disease activity in IFN␤-1a recipients may have reduced brain atrophy during the second year of observation.…”
Section: Results Patients Included In This Studymentioning
confidence: 97%
“…This may reflect the slow Wallerian degeneration in the CNS compared with the PNS (Bignami and Ralston, 1969;Cook and Wisniewski, 1973). However, 6 months after injury the GFR␣-1 immunoreactivity in degenerating white matter was still weak and not as high as in Schwann cells.…”
Section: Slow Increase Of Gfr␣-1 and Truncated Trkb Levels In Degenermentioning
confidence: 91%